Fig. 1From: Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)Ga68-DOTATATE-PET/CT images of a patient with metastatic G1 intestinal NET to the liver, bones and lymph nodes – showing high uptake be the tumor, in correlation with increased expression of somatostatin receptors, mainly SSTR2Back to article page